Study (Country) [ref] | Design | Study years | Study population | Interventions | Participants, n | Age, mean ± SD, years | Shock * , n (%) | Medications on admission, n (%) | ||
Anticoagulants | Antiplatelets | NSAIDs | ||||||||
Green 2005 (USA) 4 | RCT | 1993 – 1995 | Patients admitted with hematochezia with clinical or laboratory evidence of significant blood loss | Colonoscopy < 8 hours after admission | 50 | 68 ± 3 | 30 (60.0) | NR | NR | 29 (60.0) |
Standard care: red cell scan if ongoing bleeding, colonoscopy | 50 | 71 ± 4 | 34 (68.0) | NR | NR | 26 (52.0) | ||||
Laine 2010 (USA) 29 | RCT | 2002 – 2008 | Patients admitted with hematochezia with a high-risk feature* | Colonoscopy < 12 hours after admission | 36 | 52 ± 3 | 27 (75.0) | NR | NR | NR |
Colonoscopy 36 – 60 hours after admission | 36 | 52 ± 2 | 31 (86.1) | NR | NR | NR | ||||
Albeldawi 2014 (USA) 24 | Retrospective cohort | 2011 – 2012 | All acute LGIB | Colonoscopy < 24 hours after admission | 24 | 66.8 ± 13.8 | NR | 2 (8.3) | 13 (54.2) | 2 (8.3) |
Colonoscopy > 24 hours after admission | 33 | 69.3 ± 11.1 | NR | 7 (21.2) | 19 (57.6) | 3 (9.1) | ||||
Ishii 2011 (Japan) 17 | Retrospective cohort | 2004 – 2010 2009 – 2010 | Patients with colonic diverticular hemorrhage | EBL | 16 | NR | NR | NR | NR | NR |
Endoclipping | 48 | NR | NR | NR | NR | NR | ||||
Jacovides 2015 (USA) 25 | Historical control | 2005 – 2012 | All patients hospitalized with LGIB | Historical protocol: red cell scan, CTA or colonoscopy | 78 | 68 ± 15 | NR | NR | NR | NR |
New protocol: CTA, colonoscopy | 83 | 70 ± 15 | NR | NR | NR | NR | ||||
Jensen 2000 (USA) 30 | Historical control | 1986 – 1992 and 1994 – 1998 | Patients with hematochezia and diverticulosis | Medical and surgical intervention | 17 | 66 ± 3 | NR | NR | NR | 3 |
Medical and endoscopic therapy | 10 | 67 ± 4 | NR | NR | NR | 3 | ||||
Nagata 2016 (Japan) 27 | Retrospective cohort | 2009 – 2014 | All patients admitted with acute overt LGIB | Colonoscopy < 24 hours after admission | 163 | 67.9 ± 17.4 | 17 (10.4) | 9 (5.5) | 63 (38.7) | 23 (14.1) |
Colonoscopy > 24 hours after admission | 163 | 66.4 ± 16.9 | 19 (11.7) | 6 (11.7) | 54 (33.1) | 20 (12.3) | ||||
Nagata 2015 (Japan) 26 | Retrospective Cohort | 2008 – 2013 | Patients admitted with LGIB who underwent colonoscopy | Urgent CTA then colonoscopy | 126 | 68.3 ± 16.5 | 5 (4.0) | 7 (5.6) | 55 (43.7) | 33 |
Colonoscopy < 24 hours after admission | 97 | 67.7 ± 16.5 | 1 (1.0) | 4 (4.1) | 36 (37.1) | 13 (13.4) | ||||
Nakano 2015 (Japan) 22 | Retrospective cohort | 2004 – 2014 | Patients undergoing endoscopic therapy for colonic diverticular hemorrhage | EBL | 50 | 67 ± 13 | NR | NR | 15 | 4 |
Endoclipping | 39 | 64 ± 13 | NR | NR | 13 | 3 | ||||
Sun 2011 (USA) 20 | Retrospective cohort | 2007 – 2008 and 2008 – 2010 | All patients hospitalized with acute GI bleeding | CTA | 53 | NR | NR | NR | NR | NR |
Red cell scan | 46 | NR | NR | NR | NR | NR | ||||
Yabutani 2014 (Japan) 21 | Single retrospective cohort | 2010 – 2012 | Patients diagnosed with diverticular bleeding | CTA and colonoscopy | 57 | NR | NR | NR | NR | NR |
Yamaguchi 2006 (Japan) 23 | Single retrospective cohort | 1999 – 2004 | Consecutive patients with hematochezia | Ultrasound and colonoscopy | 111 | 58 (range 18 – 96) | NR | NR | NR | NR |
Ketwaroo 2012 (USA) 18 | Retrospective cohort | 2010 – 2011 | Suspected acute LGIB | CTA | 46 | 68.2 ± 17 | NR | NR | NR | NR |
Red cell scan | 46 | 70 ± 15 | NR | NR | NR | NR | ||||
Strate 2003 (USA) 28 | Retrospective cohort – subgroup | 1996 – 1999 | All patients admitted with ICD-9 codes representing LGIB, or a wide range of diagnoses associated with LGIB | Colonoscopy < 24 hours after admission | 69 | NR | NR | NR | NR | NR |
Colonoscopy > 24 hours after admission | 75 | NR | NR | NR | NR | NR | ||||
Rodriguez- Moranta 2007 (Spain) 19] | Prospective cohort | 2005 – 2006 | Consecutive patients admitted with LGIB | Colonoscopy < 24 hours after admission | 92 | NR | NR | NR | NR | NR |
Colonoscopy > 24 hours after admission | 88 | NR | NR | NR | NR | NR |
CTA, computed tomographic angiography; EBL, endoscopic band ligation; GI, gastrointestinal; ICD, International Classification of Diseases; LGIB, lower gastrointestinal bleeding; NR, not reported; NSAID, nonsteroidal anti-inflammatory drug; RCT, randomized controlled trial
High risk features defined as heart rate > 100, systolic blood pressure < 100 mmHg, orthostatic changes in systolic blood pressure > 20 mmHg or in heart rate > 20 beats/min, blood transfusion, or drop in hemoglobin ≥ 1.5 g/dL within a 6-hour period.